Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma

Shanghai Cell Therapy Group Co.,Ltd · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
multiple-myeloma
relapsed, refractory, multiple myeloma, relapsed/refractory multiple myeloma, car-t, cd19, cd22, bcma, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 885188
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.